RRN3P3 has been reported as an oncogenic pseudogene in breast cancer due to its correlation with lower overall survival in high-risk patients in combination with other pseudogenes, especially in patients with the basal-like subtype [97]. The gene discussed is RRN3P3; the disease is breast cancer.